Related references
Note: Only part of the references are listed.Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening-detectable findings
Idit Maya et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)
Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it?
R. Mellis et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)
First-trimester ultrasound detection of fetal heart anomalies: systematic review and meta-analysis
J. N. Karim et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2022)
Confirmation rate of cell freeDNAscreening for sex chromosomal abnormalities according to the method of confirmatory testing
Kai Luethgens et al.
PRENATAL DIAGNOSIS (2021)
Ten reasons why we should not abandon a detailed first trimester anomaly scan
Karl Oliver Kagan et al.
ULTRASCHALL IN DER MEDIZIN (2021)
Routine first-trimester ultrasound screening using a standardized anatomical protocol
Yimei Liao et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study
Lisa Hui et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort
E. Bevilacqua et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2021)
Significance of Low Maternal Serum B-hCG Levels in the Assessment of the Risk of Atypical Chromosomal Abnormalities
Robin Wijngaard et al.
FETAL DIAGNOSIS AND THERAPY (2021)
Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
J. Miranda et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2020)
Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
Francesca Bardi et al.
PRENATAL DIAGNOSIS (2020)
Antenatal screening for fetal trisomies using microarray-based cell-free DNA testing: A systematic review and meta-analysis
Julia Geppert et al.
PRENATAL DIAGNOSIS (2020)
Genome-wide cfDNA testing of maternal blood
J. C. Jani et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2020)
The epidemiology of sex chromosome abnormalities
Agnethe Berglund et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2020)
First Trimester Screening for Common Trisomies and Microdeletion 22q11.2 Syndrome Using Cell-Free DNA: A Prospective Clinical Study
Karl Oliver Kagan et al.
FETAL DIAGNOSIS AND THERAPY (2020)
DEGUM, oGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures
Peter Kozlowski et al.
ULTRASCHALL IN DER MEDIZIN (2019)
Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes
Desheng Liang et al.
GENETICS IN MEDICINE (2019)
Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples
P. Benn et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2019)
Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation
A. Syngelaki et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2019)
False-positive rates in screening for trisomies 18 and 13: a comparison between first-trimester combined screening and a cfDNA-based approach
Karl Oliver Kagan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands
Karuna R. M. van der Meij et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Noninvasive screening by cell-free DNA for 22q11.2 deletion: Benefits, limitations, and challenges
Francesca Romana Grati et al.
PRENATAL DIAGNOSIS (2019)
Prenatal Screening for 22q11.2 Deletion Using a Targeted Microarray-Based Cell-Free DNA Test
Maximilian Schmid et al.
FETAL DIAGNOSIS AND THERAPY (2018)
Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing
Glenn E. Palomaki et al.
GENETICS IN MEDICINE (2018)
Rare autosomal trisomies: Important and not so rare
Fergus Scott et al.
PRENATAL DIAGNOSIS (2018)
Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting
C. B. Miltoft et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program
I. Vogel et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing
A. Lindquist et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Expanding the fetal phenotype: Prenatal sonographic findings and perinatal outcomes in a cohort of patients with a confirmed 22q11.2 deletion syndrome
Erica Schindewolf et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2018)
Noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility exploration
Yuan Ren et al.
PRENATAL DIAGNOSIS (2018)
Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions
K. Martin et al.
CLINICAL GENETICS (2018)
The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis
F. L. Mackie et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)
Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first-trimester screening for chromosomal abnormalities
A. Syngelaki et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2017)
Cut-off value of nuchal translucency as indication for chromosomal microarray analysis
I. Maya et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2017)
Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13
M. Santorum et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2017)
Systematic review of first-trimester ultrasound screening for detection of fetal structural anomalies and factors that affect screening performance
J. N. Karim et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2017)
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis
M. M. Gil et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2017)
Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for other major defects and pregnancy complications
Karl Oliver Kagan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2017)
Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities
Karl Oliver Kagan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2017)
Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women
Mylene Badeau et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test
M. M. Gil et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
Discordance between ultrasound and cell free DNA screening for monosomy X
Karl Oliver Kagan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Development of prenatal screening-A historical overview
Howard Cuckle et al.
SEMINARS IN PERINATOLOGY (2016)
First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan
P. Wagner et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
First trimester screening for other trisomies than trisomy 21, 18, and 13
Niels Torring et al.
PRENATAL DIAGNOSIS (2015)
First trimester ultrasound screening for Down syndrome based on maternal age, fetal nuchal translucency and different combinations of the additional markers nasal bone, tricuspid and ductus venosus flow
Harald Abele et al.
PRENATAL DIAGNOSIS (2015)
First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2015)
What will be the role of first-trimester ultrasound if cell-free DNA screening for aneuploidy becomes routine?
J. D. Sonek et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2014)
Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening
O. B. Petersen et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2014)
Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma
Amin R. Mazloom et al.
PRENATAL DIAGNOSIS (2013)
Enlarged nuchal translucency in chromosomally normal fetuses: strong association with orofacial clefts
E. Timmerman et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2010)
Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2009)
Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation
N. Maiz et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2009)
Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2009)
Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2009)
Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free β-hCG and pregnancy-associated plasma protein-A
Karl O. Kagan et al.
HUMAN REPRODUCTION (2008)
First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Learning curve for Doppler assessment of ductus venosus flow at 11+0 to 13+6 weeks' gestation
N. Maiz et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Share Paper
